4//SEC Filing
Stepnowski Amy 4
Accession 0001225208-25-004785
CIK 0000874766other
Filed
May 5, 8:00 PM ET
Accepted
May 6, 4:18 PM ET
Size
29.9 KB
Accession
0001225208-25-004785
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2025-05-05$124.66/sh−2,087$260,157→ 75,363.892 total - Sale
Common Stock
2025-05-05$126.38/sh−2,806$354,622→ 70,352.892 total - Sale
Common Stock
2025-05-05$125.97/sh−15,235$1,919,183→ 46,467.892 total - Exercise/Conversion
Stock Option
2025-05-05−20,128→ 10,065 totalExercise: $69.41Exp: 2032-02-23→ Common Stock (20,128 underlying) - Sale
Common Stock
2025-05-05$126.40/sh−2,205$278,722→ 73,158.892 total - Sale
Common Stock
2025-05-05$126.06/sh−5,223$658,399→ 61,702.892 total - Exercise/Conversion
Common Stock
2025-05-05$51.87/sh+28,562$1,481,511→ 58,060.892 total - Exercise/Conversion
Common Stock
2025-05-05$69.41/sh+20,128$1,397,084→ 78,188.892 total - Sale
Common Stock
2025-05-05$124.77/sh−3,427$427,577→ 66,925.892 total - Sale
Common Stock
2025-05-05$126.01/sh−22,930$2,889,441→ 23,537.892 total - Exercise/Conversion
Stock Option
2025-05-05−28,562→ 0 totalExercise: $51.87Exp: 2031-02-23→ Common Stock (28,562 underlying) - Sale
Common Stock
2025-05-05$124.82/sh−738$92,118→ 77,450.892 total
Holdings
- 26,079
Stock Option
Exercise: $78.28Exp: 2033-02-28→ Common Stock (26,079 underlying) - 13,582
Stock Option
Exercise: $95.74Exp: 2034-02-27→ Common Stock (13,582 underlying) - 13,836
Stock Option
Exercise: $116.41Exp: 2035-02-25→ Common Stock (13,836 underlying)
Footnotes (14)
- [F1]The transaction reported on this Form 4 was effected pursuant to a trading plan previously adopted by Ms. Stepnowski on February 4, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- [F10]The options became fully exercisable on February 23, 2024, the third anniversary of the grant date.
- [F11]The options became fully exercisable on February 23, 2025, the third anniversary of the grant date.
- [F12]One-third of the options became exercisable on February 28, 2024, an additional one-third of the options became exercisable on February 28, 2025 and the remaining one-third of the options will become exercisable on February 28, 2026, the third anniversary of the grant date.
- [F13]One-third of the options became exercisable on February 27, 2025, an additional one-third of the options will become exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date.
- [F14]One-third of the options will become exercisable on February 25, 2026, an additional one-third of the options will become exercisable on February 25, 2027 and the remaining one-third of the options will become exercisable on February 25, 2028, the third anniversary of the grant date.
- [F2]Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $124.48 - $125.33 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $124.27 - $125.02 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F4]Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $126.37 - $126.51 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F5]Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $126.32 - $126.51 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F6]Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $124.35 - $125.34 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F7]Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $125.56 - $126.49 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F8]Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $125.32 - $126.32 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F9]Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $125.37 - $126.36 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Documents
Issuer
HARTFORD INSURANCE GROUP, INC.
CIK 0000874766
Entity typeother
Related Parties
1- filerCIK 0001820324
Filing Metadata
- Form type
- 4
- Filed
- May 5, 8:00 PM ET
- Accepted
- May 6, 4:18 PM ET
- Size
- 29.9 KB